BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190605
DTSTAMP:20260514T223707
CREATED:20190228T102509Z
LAST-MODIFIED:20190228T102724Z
UID:19778-1559520000-1559692799@www.pharmajournalist.com
SUMMARY:Lyophilisation
DESCRIPTION:SMi Presents their 7th Annual Lyophilisation Conference \nSMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019\, in London\, UK. \n \nLyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020\, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion. \nAttend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science\, materials characterisation\, novel and alternative technologies\, mathematical modelling and regulatory updates. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \nCHAIRS FOR 2019  \nSune Klint Andersen\, Principal Spray Drying\, Janssen Pharmaceuticals \nXiaodong Chen\, Senior Research Investigator\, Bristol-Myers Squibb \nKEY SPEAKERS INCLUDE: \n\nPaul Matejtschuk\, Principal Scientist & Section Head\, Standardisation Science\, NIBSC\nDavide Fissore\, Associate Professor\, Politecnico di Torino\nMichael Dekner\, Head Fill & Finish LCM support\, Takeda\nRichard Denk\, Head Sales Containment\, Skan AG\nMostafa Nakach\, Head of Pharmaceutical Engineering Group\, Sanofi-Aventis R&D\nDaryl Williams\, Professor of Particle Science and Director of Discovery space\, Imperial College London\nKevin Ward\, Director of R&D\, Biopharma technology\nPaul Barry\, Development Scientist\, Genzyme Ireland Ltd/Sanofi\n\n2019 HIGHLIGHTS \n\nExplore the recent advances in lyophilisation methods and technologies from Biopharma Technology\nDiscuss the novel methods that characterise complex pharmaceutical products to aid formulation design from NIBSC\nGain insight into the approaches to avoid cross contamination during lyophilisation from SKAN AG\nDiscover a new approach towards process design through the use of micro freeze dryers by Politecno di Torino\nExamine the use of model-based approach to lyophilisation cycle design from Takeda\n\nFor more information on 7th Annual Lyophilisation Conference\, visit: www.lyophilisation-europe.com/PJ \nEarly-Bird Rates \n\nBOOK BY 29TH MARCH AND SAVE £400\nBOOK BY 30TH APRIL AND SAVE £200\nBOOK BY 31ST MAY AND SAVE £100\n\nContact Info\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilisation-conference-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190604
DTEND;VALUE=DATE:20190607
DTSTAMP:20260514T223707
CREATED:20171216T022447Z
LAST-MODIFIED:20190404T074100Z
UID:5446-1559606400-1559865599@www.pharmajournalist.com
SUMMARY:Digital Pharma Europe
DESCRIPTION:The 11th Digital Pharma Europe\, hosted by Meck Serono in Rome\, will focus on helping pharma understand how to evolve and adapt to the rapidly changing global healthcare ecosystem\, and to the rapidly changing needs and dynamics of its customers. In essence: Understand Digital Marketing and the Evolution of The Engagement Model In The Era of AI. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2UrQr1e
URL:https://www.pharmajournalist.com/event/digital-pharma-europe/
LOCATION:Merck Serono Headquarters\, Via Casilina 125\, Rome\, 00176\, Italy
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260514T223707
CREATED:20190522T081845Z
LAST-MODIFIED:20190522T081845Z
UID:20818-1559692800-1559865599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2019
DESCRIPTION:Facilitating a platform for the San Diego biotech hub to refine their clinical trial supply strategy to remain patient focused whilst staying at the forefront of an ever-changing landscape. \n2019 will celebrate the 9th year Arena International brings the global Clinical Trial Supply series to San Diego\, giving decision makers from small\, medium and large pharmaceutical companies the opportunity to as inject agility\, transparency and speed into your clinical trial supply. \nThis event brings the unique San Diego biotech hub together to discuss the best methodologies for ensuring successful clinical trial supply. We will focus on the full supply chain\, starting with the front end all the way to site and direct to patient delivery. Delving into the finer details we will ensure the smooth running of trial supplies\, to not only start and finish on time\, but also to meet budgetary constraints. \nAvoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions\, roundtables\, fireside chats and case studies to give rise to innovation solutions to existing challenges. \nThe key topics to be addressed will be: \n\nForecasting and Planning\nPackaging and Labelling\nUnique trial design e.g. adaptive\, compassionate use and at home delivery\nBrexit\nNew technologies\n\nJoin us in June in San Diego to be a part of the discussions and develop unique insight for clinical trial supply.
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2019/
LOCATION:Marriot Del Mar\, San Diego\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190618
DTEND;VALUE=DATE:20190621
DTSTAMP:20260514T223707
CREATED:20181113T085750Z
LAST-MODIFIED:20181128T092809Z
UID:18371-1560816000-1561075199@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China 2019
DESCRIPTION:As the most comprehensive pharmaceutical exhibition in Asia\, CPhI & P-MEC China has\, since its launch in 2001\, been fostering international pharmaceutical business exchanges and leading market trends and technical innovations in the entire industry. Based in Shanghai and with a global vision\, CPhI & P-MEC China is emanating its influences by creating a trading & sourcing platform\, gathering quality suppliers\, sharing cutting-edge knowledge\, and building up an elite pharma professional network. \n \nCPhI & P-MEC China 2019 will be held in Shanghai on June 18-20\, 2019. The annual pharma gala are expected to gather 70\,000+ visits and showcase 3\,200+ exhibitors in a 200\,000+ square metre space. Welcome to join us in CPhI & P-MEC China 2019! \n  \nTo learn more and to register online\, visit: http://bit.ly/2r8jnuD
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-2019/
LOCATION:SNIEC\, Shanghai\, China
ORGANIZER;CN="UBM":MAILTO:Yingqi.shi@ubmsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190619
DTEND;VALUE=DATE:20190622
DTSTAMP:20260514T223707
CREATED:20190220T075016Z
LAST-MODIFIED:20190220T075016Z
UID:19657-1560902400-1561161599@www.pharmajournalist.com
SUMMARY:8th Annual HPAPI Summit
DESCRIPTION:Enabling Robust\, Safe and Cost-Effective Productionof Highly Potent APIs \nIn the context of ever-increasing drug potency\, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds\, enabling you to implement safe and robust practices in your own organization. \nIncorporating insights from Genentech\, Pfizer\, Boehringer Ingelheim\, SafeBridge and AbbVie\, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly\, safely and cost-effectively.
URL:https://www.pharmajournalist.com/event/8th-annual-hpapi-summit/
LOCATION:The Westin Waltham Boston  70\, Third Avenue  Waltham\,Boston  Massachusetts 02451
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190624
DTEND;VALUE=DATE:20190627
DTSTAMP:20260514T223707
CREATED:20190326T120821Z
LAST-MODIFIED:20190326T121125Z
UID:20086-1561334400-1561593599@www.pharmajournalist.com
SUMMARY:GI Inflammatory Diseases Summit (GIIDS)
DESCRIPTION:Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases \nThe GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease. \nIncorporating insights from leading pharma and pioneering biotech\, this discussion and networking forum will curate the cutting edge insights on: \n\nImproving drug safety profiles of more gut-selective compounds\nOptimizing trial design in a hypercompetitive market\nThe promise of microbiome based biotherapeutics\n\nJoin gastroenterology\, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.
URL:https://www.pharmajournalist.com/event/gi-inflammatory-diseases-summit-giids/
LOCATION:Revere Hotel Boston Common  200 Stuart Street  Boston\, MA\, 02116  USA\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260514T223707
CREATED:20190418T090640Z
LAST-MODIFIED:20190418T090640Z
UID:20372-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:2nd Combination Products Lifecycle Management Summit
DESCRIPTION:Returning to Boston for its 2nd successful year in 2019\, the CPLM Summit features a fresh speaker line-up including the FDA\, Alnylam\, kaleo\, Novartis and many others\, as well as a pre-conference focus day to give you a comprehensive LCM guide to your combination products. \n \nLifecycle management for drug-device combination product has stolen the spotlight amongst pharma\, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is a lot of potential and many benefits to having such a mind-set and implementing a robust LCM program from the get-go. \nAs the only peer-led community\, we will bring in 100+ senior leaders from drug-device teams including the regulatory affairs\, product development and quality to share their view and encourage collaborative efforts. \nFor more information on 2nd Annual CPLM Summit\, visit https://ter.li/11hr26
URL:https://www.pharmajournalist.com/event/2nd-annual-cplm-summit/
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260514T223707
CREATED:20190426T082151Z
LAST-MODIFIED:20190426T082638Z
UID:20510-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:Cell Engager Summit
DESCRIPTION:The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic. \n \nOvercome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug. \nDiscover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies. \nWith 22+ hours of content\, 2 interactive workshops and over 5 hours of networking with key industry leaders\, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges. \nJoin us as we unite experts from across large pharma\, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies. \nTo learn more and to register online\, visit cell-engager-summit.com
URL:https://www.pharmajournalist.com/event/cell-engager-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190629
DTSTAMP:20260514T223707
CREATED:20190225T142502Z
LAST-MODIFIED:20190225T142702Z
UID:19737-1561507200-1561766399@www.pharmajournalist.com
SUMMARY:4th Microbiome Movement – Drug Development Summit
DESCRIPTION:4th Microbiome Movement – Drug Development Summit\nJune 26-28\, 2019 | Boston\, MA \n \nReturning for the fourth year\, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical\, biotech and academic community pursue the causal role of the human microbiome in disease\, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs. \nIf you are\, or would like to be\, a player in the microbiome arena\, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics\, biomarkers and diagnostics\, but also make long-lasting connections that will accelerate your microbiome developments forward\, and help translate this promising science into a reality for patients. \nHear from 60+ expert speakers including: \n\nAlison Lawton\, CEO\, Kaleido Biosciences\nBernat Olle\, CEO\, Vedanta Biosciences\nCathryn Nagler\, Bunning Food Allergy Professor\, University of Chicago\nEric Shaff\, CEO\, Seres Therapeutics\nEsi Lamouse-Smith\, Director\, Janssen Pharmaceuticals\nKen Blount\, CSO\, Rebiotix\nMike Romanos\, CEO\, Microbiotica\nUlrich Thienel\, Chief Medical Officer\, Finch Therapeutics Group\n\nSee the complete agenda and speaker list: https://ter.li/nefsqj \nEarly booking rates and group discounts are available. Visit the website to learn more: https://ter.li/1bcb5n.
URL:https://www.pharmajournalist.com/event/4th-microbiome-movement-drug-development-summit/
LOCATION:Revere Boston Common Hotel\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20260514T223707
CREATED:20190409T072829Z
LAST-MODIFIED:20190409T072829Z
UID:20257-1561507200-1561593599@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27\, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.  \n\nThe Pharma Gorilla | June 26\, 2019 | Le Meridien Singapore\, Sentosa\nThe Pharma Gorilla | Nov 07\, 2019 | New Delhi\, India\n\n The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe conference program have been designed in such way which can cover the trending topics under Keynote session\, exclusive presentation\, product lunch\, panel and round table discussion and it also provides a meaningful information. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition. \nTarget Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies\, software development companies\, CRO\, manufacturing\, formulation\, digital marketing and data management companies. \nGlimpse of Conference Agenda! \n Conference Panels \n\nArtificial Intelligence in Pharma and Healthcare\nA disruptive take on marketing: Digital Marketing comes to Pharma\nScope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry\nLatest Trends in Formulation Development: A Global Perspective\nThe Impact of Regulatory Reform on Innovation in Drug Delivery Systems\n\nRoundtable Discussion \n\nImproving patient engagement and experience to improve clinical trials\n\n Keynote Session \n\nInnovation-driven and emerging technologies of Pharma Industry in Asia\nThe Global Pharma Industry: Policies\, Regulations and Key Trends 2019-2020\n\nExclusive Presentation \n\nRole of IPR in pharmaceutical industry\nCareer Growth Opportunities in the pharmaceutical industry\nImproving Biosimilars in manufacturing data\n\nFor any query\, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla-2/
LOCATION:Le Meridien Singapore\, Sentosa
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
END:VCALENDAR